[PDF] Top 20 Formulation and development of some BCS Class II drugs
Has 10000 "Formulation and development of some BCS Class II drugs" found on our website. Below are the top 20 most common "Formulation and development of some BCS Class II drugs".
Formulation and development of some BCS Class II drugs
... Ezetimibe was dissolved without changing solvent PG for the preparation of solution of drug. The combination of coating and carrier materials transferred Avicel PH102 as carrier and colloidal silicon dioxide (Aerosil ... See full document
9
FORMULATION AND DEVELOPMENT OF TOPICAL NIOSOMAL GEL OF BCS CLASS - III ANTI-VIRAL DRUG FOR BETTER EFFICACY AS HERPES TREATMENT
... For the niosome preparation, various methods have been reported, among them thin layer hydration (TLE) method was selected. The sorbitan monostearate was selected for experimental purpose as its HLB values is 4.7 and ... See full document
6
Formulation and Development OF BCS Class II Drug
... a BCS class II ...selected formulation FV10 containing 30% of drug solution has shown good drug release of ...selected formulation shows that drug present in the formulation is ... See full document
8
Development and Validation of Analytical Methods for Quantification of Some Novel Drugs in Formulation.
... Formulation 4 : Cilastatin sodium and Imipenem 43 Linearity range UV Spectrophotometry 44 Analytical performance UV Spectrophotometry 45 Recovery Data UV Spectrophotometry 46 Repeatab[r] ... See full document
258
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SOME DRUGS IN PHARMACEUTICAL FORMULATION
... Standard stock solution A and B were diluted separately with mobile phase to obtain final concentration of 24 µg/ml of ASP and 60 µg/ml of TIC. Each solution was scanned using double beam UV-Visible ... See full document
10
LIQUISOLID SYSTEMS - AN EMERGING STRATEGY FOR SOLUBILIZATION & DISSOLUTION RATE ENHANCEMENT OF BCS CLASS-II DRUGS
... lipophilic drugs/water insoluble drugs in order to increase their clinical ...medications. Formulation and manufacture of liquisolid tablets is quite simple method according to new mathematical model ... See full document
11
Formulation and invitro evaluation of albendazole nanosuspensions
... Nanotechnology opens up new vistas of research in the development of novel drug delivery systems. “Nano” word comes from the Greek word „nanos” which means dwarf. Nano means it is the factor of 10 -9 or one ... See full document
5
EVALUATION OF A NEW COPROCESSED EXCIPIENT AS CARRIER FOR ENHANCING THE DISSOLUTION RATE OF POORLY SOLUBLE BCS CLASS II DRUGS
... higher dissolution of drug from the tablets formulated employing SD dispersions with both aceclofenac and valdecoxib when compared to control formulations.All aceclofenac tablets formulated and commercial fulfilled the ... See full document
6
Journal of Applied Pharmaceutical Science
... the formulation and development of the ...drug development, specifically for solid dosage forms like tablets (Lachman et al, ...tablet formulation used for binding between drug and other ... See full document
5
LIQUISOLID TECHNIQUE: A NOVEL APPROACH TO ENHANCE SOLUBILITY AND BIOAVAILABILITY OF BCS-II DRUGS
... Development of sustained release oral dosage forms is beneficial for optimal therapy in terms of efficacy, safety and patient compliance. There are several techniques for preparation of sustained release ... See full document
8
Solubility Enhancement of BCS Class II Drug By Solid Dispersion Technique – Fabrication and Evaluation.
... reproducibility, formulation, scale up and stability limited its use in commercial dosage forms for poorly water-soluble ...Successful development of solid dispersion systems for preclinical, clinical and ... See full document
114
IMPROVING SOLUBILITY OF BCS CLASS II DRUGS USING SOLID DISPERSION: A REVIEW
... Due to the advantageous features of solid dispersions formulation scientists consider it as one of the most potential method of improving oral bioavailability. But changes in crystal behavior of drug and/or ... See full document
7
ENHANCEMENT OF BIOAVAILABILITY OF VALSARTAN THROUGH NANOCRYSTAL FORMULATION
... The aim of the present study was focused on the development of nanocrystals of valsartan, an antihypertensive drug to be administered through oral route. Five formulations (F1, F2, F3, F4 & F5) of nanocrystals ... See full document
17
Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs
... drug development and formulation studies (Markopoulos et ...of BCS class II drugs, a statistical design of experiment (DoE) approach was applied to investigate the in fl uence of ... See full document
10
DEVELOPMENT AND VALIDATION OF UPLC METHOD FOR ESTIMATION OF % RELEASE OF SOME ANTI HIV DRUGS IN FIXED DOSE COMBINATION
... The selected column was a UPLC BEH (50 × 2.1 mm; 1.7 µm) (Waters). Mobile phase consisted of 20mM phosphate buffer pH-2.5 ± 0.05 with 0.1% TEA (A), acetonitrile (B). Samples were eluted with an increasing gradient of ... See full document
6
LIQUISOLID COMPACT TECHNOLOGY: A REVIEWG. Geethika*, Kameswara Rao. S, B. Ravindra Babu, K. Kumar Babu,M. Mamatha. Murali, V. BhagyarajuDOWNLOAD/VIEW
... and Class IV, compounds which feature poor solubility and poor permeability ...(BCS) class II and IV, dissolve slowly, poorly and irregularly, and hence pose serious delivery challenges, like ... See full document
8
Influence of physiological gastrointestinal surfactant ratio on the equilibrium solubility of BCS class II drugs investigated using a four component mixture design
... water-soluble drugs is in fl uenced by the luminal gastrointestinal fl uid content and composition, which control ...soluble drugs through more complex biorelevant amphiphile ...spironolactone) drugs ... See full document
13
Preparation and in vitro Evaluation of Fast Disintegrating Tablets of BCS Class II Drug
... a BCS class II drug having absolute bioavailability of approximately ...(SF1-SF4),(KF1-KF4) formulation(SF4) containing Pranlukast+ ß cyclodextrin ...best formulation. From the ... See full document
5
FORMULATION AND EVALUATION OF ACECLOFENAC MATRIX TABLETS USING ETHYL CELLULOSE AND CELLULOSE ACETATE PHTHALATE
... a BCS class II drug by wet granulation method, using Ethyl cellulose (EC) and Calcium Acetate Phthalate ...best formulation since it minimized the initial drug release of the drug to the ... See full document
7
EFFECT OF PHYSICAL MODIFICATION ON DISSOLUTION OF NABUMETONE: A BCS CLASS II DRUG
... a BCS class II non-steroidal anti- inflammatory drug (NSAID) used in the treatment of osteoarthritis (OA) and rheumatoid arthritis (RA) 9, 10, 11, 12 ...soluble drugs 22, ... See full document
7
Related subjects